• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOARRAY SOLUTIONS LTD. HEA 1.2 BEADCHIP KIT, PLATE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOARRAY SOLUTIONS LTD. HEA 1.2 BEADCHIP KIT, PLATE Back to Search Results
Model Number 800-20202-96
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 11/20/2019
Event Type  malfunction  
Event Description
The customer reported a possible discrepancy.The donor is c+ using the bioarray hea molecular beadchip kit; serology results were c-.
 
Manufacturer Narrative
Rhce exon 2 analysis: by using the exon 2 amplification primers published by haer-wigman et al (2013)1, the sample is homozygous c.307c indicative of c+ phenotype in both forward and reverse sequences as shown in the sequencing report.To verify above sequencing result, the sample was also amplified by two sets of rhce exon 2 primers followed by sanger sequencing using three primers published by volkova et al (2019)2.The 1.3 kb f3-r1 amplicon from the sample generates the scrambled sequence using the seqf1-s sequencing primer.The 1.7 kb f4-r4 pcr product generates the scrambled sequence from the forward primer seqf4, and a readable sequence from the reverse primer seqr4 indicative of homozygous c.307t as shown below.In sanger sequencing, the scramble sequencing read from a pcr amplicon is due to undesignated polymorphism in the amplicon sequence, pcr primer and/or sequencing primer regions in one or two alleles of the target gene.All exons of the rhce gene have been sequenced for this sample.Except for exon 2 encoding the rhc antigen, the sequencing results are consistent with hea tests for the c+ e+ e- v- vs- phenotypes.Further investigation will be required to determine root cause for the conflict rhc phenotype in sequencing as well as in hea assay.
 
Event Description
The customer reported a possible discrepancy.The donor is c+ using the bioarray hea molecular beadchip kit; serology results were c-.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEA 1.2 BEADCHIP KIT, PLATE
Type of Device
HEA 1.2 BEADCHIP KIT, PLATE
Manufacturer (Section D)
BIOARRAY SOLUTIONS LTD.
35 technology drive
suite 100
warren NJ 07059
MDR Report Key9503506
MDR Text Key191919811
Report Number3005967741-2019-00018
Device Sequence Number1
Product Code PEP
UDI-Device Identifier10888234100065
UDI-Public10888234100065
Combination Product (y/n)N
PMA/PMN Number
BP130026
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type user facility
Type of Report Initial,Followup
Report Date 02/20/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/20/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator No Information
Device Expiration Date09/30/2020
Device Model Number800-20202-96
Device Catalogue Number800-20202-96
Device Lot Number19-96-V
Was Device Available for Evaluation? Yes
Date Manufacturer Received11/20/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-